TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients

BACKGROUND: Chemotherapy is the preferred treatment in many types of cancer including lung cancer. However, most of patients resist chemotherapy resulting in disease progressive and recurrence. Titin (TTN) mutation is proved as a beneficial role in lung squamous carcinoma (LUSC), but the predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Dan, Lin, Hongguang, Lin, Lan, Wei, Qiongying, Yang, Sheng, Chen, Xiangqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798240/
https://www.ncbi.nlm.nih.gov/pubmed/35116455
http://dx.doi.org/10.21037/tcr-20-2568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798240/
https://www.ncbi.nlm.nih.gov/pubmed/35116455
http://dx.doi.org/10.21037/tcr-20-2568

Ejemplares similares